FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT

LONDON--()-- 

Ap19

FORM 8.3 - Amendment to purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 04 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,864,894

1.45%

231,530

0.18%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

94,581

0.07%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,943,353

1.51%

332,211

0.26%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

1

257.6900 USD

Purchase

2

258.0400 USD

Purchase

3

259.8200 USD

Purchase

5

259.6180 USD

Purchase

5

257.5440 USD

Purchase

13

257.9469 USD

Purchase

14

256.3600 USD

Purchase

15

259.5346 USD

Purchase

35

256.4200 USD

Purchase

68

258.4900 USD

Purchase

83

256.6534 USD

Purchase

102

260.4370 USD

Purchase

171

258.7400 USD

Purchase

190

260.2721 USD

Purchase

200

258.6375 USD

Purchase

300

258.6300 USD

Purchase

353

260.4420 USD

Purchase

410

257.9000 USD

Purchase

476

260.3720 USD

Purchase

507

257.8273 USD

Purchase

514

258.3779 USD

Purchase

910

259.6878 USD

Purchase

953

258.3477 USD

Purchase

983

257.7908 USD

Purchase

1,102

257.2963 USD

Purchase

1,130

258.0164 USD

Purchase

2,176

258.6069 USD

Purchase

2,684

259.7866 USD

Purchase

3,753

260.5128 USD

Purchase

4,429

257.8573 USD

Purchase

5,334

258.3442 USD

Purchase

6,539

259.5923 USD

Purchase

7,657

258.4409 USD

Purchase

22,055

256.6217 USD

Purchase

22,526

258.0725 USD

Purchase

31,259

259.7300 USD

Sale

1

256.4700 USD

Sale

1

258.5800 USD

Sale

3

257.6500 USD

Sale

4

256.8875 USD

Sale

70

257.5800 USD

Sale

90

257.8547 USD

Sale

100

256.6000 USD

Sale

100

257.9700 USD

Sale

100

256.9600 USD

Sale

103

257.9835 USD

Sale

104

258.3220 USD

Sale

136

258.7400 USD

Sale

200

258.1350 USD

Sale

200

256.6500 USD

Sale

300

256.7500 USD

Sale

400

256.7375 USD

Sale

406

256.8012 USD

Sale

567

258.5375 USD

Sale

791

259.4937 USD

Sale

910

259.6878 USD

Sale

940

256.7765 USD

Sale

1,047

257.5087 USD

Sale

1,270

259.7300 USD

Sale

1,499

257.8919 USD

Sale

1,989

259.6121 USD

Sale

1,990

258.3417 USD

Sale

2,216

256.7358 USD

Sale

2,700

258.4094 USD

Sale

3,704

257.5944 USD

Sale

4,046

258.3765 USD

Sale

5,870

256.9059 USD

Sale

7,504

258.4356 USD

Sale

10,038

260.5217 USD

Sale

11,623

256.4300 USD

Sale

11,931

259.7299 USD

Sale

19,087

259.6931 USD

Sale

25,350

257.9964 USD

(b) Derivatives transactions (other than options transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per

 

 

unit

SWAP

Long

71,000

259.7300 USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

8 Jun 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or

Number of

Exercise

Type

Expiry

purchased

relevant securities

price

 

date

 

to which the option

 

 

 

 

or derivative

 

 

 

 

relates

 

 

 

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 738830
Time of Receipt (offset from UTC): 20210608T105731+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC